Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Individuals with mild cognitive impairment (MCI) have a substantially increased risk of developing dementia due to Alzheimer's disease (AD). In this study, we developed a multivariate prognostic model for predicting MCI-to-dementia progression at the individual patient level. METHODS: Using baseline data from 259 MCI patients and a probabilistic, kernel-based pattern classification approach, we trained a classifier to distinguish between patients who progressed to AD-type dementia (n = 139) and those who did not (n = 120) during a three-year follow-up period. More than 750 variables across four data sources were considered as potential predictors of progression. These data sources included risk factors, cognitive and functional assessments, structural magnetic resonance imaging (MRI) data, and plasma proteomic data. Predictive utility was assessed using a rigorous cross-validation framework. RESULTS: Cognitive and functional markers were most predictive of progression, while plasma proteomic markers had limited predictive utility. The best performing model incorporated a combination of cognitive/functional markers and morphometric MRI measures and predicted progression with 80% accuracy (83% sensitivity, 76% specificity, AUC = 0.87). Predictors of progression included scores on the Alzheimer's Disease Assessment Scale, Rey Auditory Verbal Learning Test, and Functional Activities Questionnaire, as well as volume/cortical thickness of three brain regions (left hippocampus, middle temporal gyrus, and inferior parietal cortex). Calibration analysis revealed that the model is capable of generating probabilistic predictions that reliably reflect the actual risk of progression. Finally, we found that the predictive accuracy of the model varied with patient demographic, genetic, and clinical characteristics and could be further improved by taking into account the confidence of the predictions. CONCLUSIONS: We developed an accurate prognostic model for predicting MCI-to-dementia progression over a three-year period. The model utilizes widely available, cost-effective, non-invasive markers and can be used to improve patient selection in clinical trials and identify high-risk MCI patients for early treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“Importantly, our results provide empirical support to the most recently revised clinical criteria for MCI, where the concept of “MCI due to AD” is proposed to include “impairment in one or more cognitive domains” and an allowance for “mild problems performing complex functional tasks” [70].”
ResultA concordance correlation coefficient to evaluate reproducibility.
Lin, L. I.-K. (1989) · Biometrics · doi:10.2307/2532051 · Cited by 8,785
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“This finding is consistent with the AD biomarker model proposed by Jack and colleagues [67], which states that different biomarkers have unique temporal trajectories and may be optimally sensitive to AD-related changes during specific time periods.”
ResultThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 1×
“Finally, although in this study we considered only the APOE genotype as a generic predictor of progression, genomewide association studies have been used to identify several other genes that likely contribute to the development of AD [85].”
Cited by
Rathore, S., Habes, M., Iftikhar, M. A., Shacklett, A., & Davatzikos, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.057 · Cited by 622
“They used mutual information criterion for feature selection and probabilistic multi-kernel learning for classification (Korolev et al., 2016).”
Spasov, S., Passamonti, L., Duggento, A., Liò, P., & Toschi, N. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.01.031 · Cited by 425
Lu, D., Popuri, K., Ding, G. W., Balachandar, R., Beg, M. F., Initiative, A. D. N., Weiner, M., Aisen, P., Petersen, R., Jack, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22871-z · Cited by 376
Self-citationMachine Learning Techniques for the Diagnosis of Alzheimer’s Disease: A Review
Tanveer, M., Richhariya, B., Khan, R. U., Rashid, A. H., Khanna, P., Prasad, M., & Lin, C. T. (2020) · ACM Transactions on Multimedia Computing, Communications, and Applications · doi:10.1145/3344998 · Cited by 329
Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease
Shanbhag, N. M., Evans, M. D., Mao, W., Nana, A. L., Seeley, W. W., Adame, A., Rissman, R. A., Masliah, E., & Mucke, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0723-5 · Cited by 214
Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214
Bhagwat, N., Viviano, J. D., Voineskos, A. N., Chakravarty, M. M., & Initiative, A. D. N. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006376 · Cited by 157
Self-citationContributions of DNA Damage to Alzheimer’s Disease
Lin, X., Kapoor, A., Gu, Y., Chow, M. J., Peng, J., Zhao, K., & Tang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051666 · Cited by 117
“Using two independent cohorts (n = 13 and n = 23), significant increases in γH2AX were recently demonstrated in astrocytes and neurons in the hippocampus and frontal cortex of AD brains [44]; the increase occurred in brains with mild cognitive impairment (MCI) [44], a preclinical stage of AD [45,46], suggesting an imp…”
BackgroundAnsart, M., Epelbaum, S., Bassignana, G., Bône, A., Bottani, S., Cattai, T., Couronné, R., Faouzi, J., Koval, I., Louis, M., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101848 · Cited by 116
Thung, K.-H., Yap, P.-T., Adeli, E., Lee, S.-W., & Shen, D. (2018) · Medical Image Analysis · doi:10.1016/j.media.2018.01.002 · Cited by 89
Yang, Y.-W., Liou, S.-H., Hsueh, Y.-M., Lyu, W.-S., Liu, C.-S., Liu, H.-J., Chung, M.-C., Hung, P.-H., & Chung, C.-J. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.07.015 · Cited by 82
Mao, C., Xu, J., Rasmussen, L., Li, Y., Adekkanattu, P., Pacheco, J., Bonakdarpour, B., Vassar, R., Shen, L., Jiang, G., et al. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104442 · Cited by 67
Huang, M., Yang, W., Feng, Q., Chen, W., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2017) · Scientific Reports · doi:10.1038/srep39880 · Cited by 55
Qi, Z., Zhao, Y., Su, Y., Cao, B., Yang, J.-J., & Xing, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.685088 · Cited by 44
“MRI presents a sensitive diagnosis of AIS, but is time-consuming and expensive, and is not available in all emergency departments (Korolev et al., 2016).”
BackgroundDeep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease
Yang, L., Wang, X., Guo, Q., Gladstein, S., Wooten, D., Li, T., Robieson, W. Z., Sun, Y., Huang, X., & Initiative, F. T. A. D. N. (2021) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2021.1884129 · Cited by 28
Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype
Li, H.-T., Yuan, S.-X., Wu, J.-S., Gu, Y., & Sun, X. (2021) · Brain Sciences · doi:10.3390/brainsci11060674 · Cited by 27
“VBpMKL is a Bayesian classification algorithm for integrating multiple feature spaces using a kernel combination methodology, which has been applied to protein fold recognition and disease conversion [26,27].”
MethodShi, J., Jia, J., Tian, S., Zhang, H., An, K., Zhu, W., Cao, W., Yuan, Y., & Wang, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.619916 · Cited by 20
Pan, J., Fan, Z., Smith, G. E., Guo, Y., Bian, J., & Xu, J. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70128 · Cited by 19
Metadata
- Authors
- Korolev, I. O., Symonds, L. L., Bozoki, A. C., & Initiative, A. D. N.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-22
- Volume
- 11
- Issue
- 2
- Pages
- e0138866
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2281498324
- Cited by
- 194
- References
- 34
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.